| Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG SF Carter, M Schöll, O Almkvist, A Wall, H Engler, B Långström, ... Journal of Nuclear Medicine 53 (1), 37-46, 2012 | 456 | 2012 |
| Positron emission tomography imaging in dementia K Herholz, SF Carter, M Jones British Institute of Radiology, 2007 | 320 | 2007 |
| Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease E Rodriguez-Vieitez, L Saint-Aubert, SF Carter, O Almkvist, K Farid, ... Brain 139 (3), 922-936, 2016 | 286 | 2016 |
| Astrocyte biomarkers in Alzheimer’s disease SF Carter, K Herholz, P Rosa-Neto, L Pellerin, A Nordberg, ER Zimmer Trends in molecular medicine 25 (2), 77-95, 2019 | 263 | 2019 |
| A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease A Nordberg, SF Carter, J Rinne, A Drzezga, DJ Brooks, R Vandenberghe, ... European journal of nuclear medicine and molecular imaging 40 (1), 104-114, 2013 | 223 | 2013 |
| Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease A Prestia, A Caroli, WM van der Flier, R Ossenkoppele, B Van Berckel, ... Neurology 80 (11), 1048-1056, 2013 | 214 | 2013 |
| Imaging biomarkers in neurodegeneration: current and future practices PNE Young, M Estarellas, E Coomans, M Srikrishna, H Beaumont, ... Alzheimer's research & therapy 12, 1-17, 2020 | 163 | 2020 |
| Mild cognitive impairment with suspected nonamyloid pathology (SNAP): prediction of progression A Caroli, A Prestia, S Galluzzi, C Ferrari, WM Van Der Flier, ... Neurology 84 (5), 508-515, 2015 | 151 | 2015 |
| Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography M Schöll, SF Carter, E Westman, E Rodriguez-Vieitez, O Almkvist, ... Scientific reports 5, 16404, 2015 | 136 | 2015 |
| Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics A Prestia, A Caroli, SK Wade, WM Van Der Flier, R Ossenkoppele, ... Alzheimer's & Dementia 11 (10), 1191-1201, 2015 | 101 | 2015 |
| Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis B Bellaver, JP Ferrari-Souza, L Uglione da Ros, SF Carter, ... Neurology 96 (24), e2944-e2955, 2021 | 85 | 2021 |
| Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease SF Carter, D Caine, A Burns, K Herholz, MA Lambon Ralph International journal of geriatric psychiatry 27 (4), 423-432, 2012 | 80 | 2012 |
| Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease E Rodriguez-Vieitez, SF Carter, K Chiotis, L Saint-Aubert, A Leuzy, ... Journal of Nuclear Medicine 57 (7), 1071-1077, 2016 | 78 | 2016 |
| Use of amyloid-PET to determine cutpoints for CSF markers A multicenter study MD Zwan, JO Rinne, SG Hasselbalch, A Nordberg, A Lleó, SK Herukka, ... Neurology 86 (1), 50-58, 2016 | 73 | 2016 |
| Relevance of biomarkers across different neurodegenerative diseases AJ Ehrenberg, A Khatun, E Coomans, MJ Betts, F Capraro, EH Thijssen, ... Alzheimer's research & therapy 12, 1-11, 2020 | 67 | 2020 |
| Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET P Edison, SF Carter, JO Rinne, G Gelosa, K Herholz, A Nordberg, ... Neuroimage 70, 423-433, 2013 | 67 | 2013 |
| Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients ILH Choo, SF Carter, ML Schöll, A Nordberg European journal of nuclear medicine and molecular imaging 41 (11), 2120-2126, 2014 | 65 | 2014 |
| The EMIF-AD PreclinAD study: study design and baseline cohort overview E Konijnenberg, SF Carter, M Ten Kate, A Den Braber, J Tomassen, ... Alzheimer's research & therapy 10, 1-12, 2018 | 57 | 2018 |
| Concordance and Diagnostic Accuracy of [11 C] PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease A Leuzy, SF Carter, K Chiotis, O Almkvist, A Wall, A Nordberg Journal of Alzheimer's Disease, 2015 | 49 | 2015 |
| Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease SF Carter, K Chiotis, A Nordberg, E Rodriguez-Vieitez European Journal of Nuclear Medicine and Molecular Imaging 46, 348-356, 2019 | 46 | 2019 |
